Osborne Partners Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $361K | Buy |
2,811
+400
| +17% | +$46.8K | 0.02% | 170 |
|
|
2026
Q1 | $290K | Hold |
2,411
| – | – | 0.02% | 174 |
|
|
2025
Q4 | $254K | Hold |
2,411
| – | – | 0.01% | 182 |
|
|
2025
Q3 | $202K | Buy |
+2,411
| New | +$199K | 0.01% | 202 |
|
|
2025
Q2 | – | Sell |
-2,860
| Closed | -$257K | – | 211 |
|
|
2025
Q1 | $257K | Buy |
2,860
+6
| +0.2% | +$560 | 0.01% | 189 |
|
|
2024
Q4 | $284K | Sell |
2,854
-426
| -13% | -$43.9K | 0.02% | 195 |
|
|
2024
Q3 | $372K | Sell |
3,280
-1
| -0% | -$119 | 0.02% | 172 |
|
|
2024
Q2 | $406K | Buy |
3,281
+75
| +2% | +$9.66K | 0.02% | 170 |
|
|
2024
Q1 | $423K | Sell |
3,206
-113
| -3% | -$13.9K | 0.03% | 160 |
|
|
2023
Q4 | $362K | Buy |
3,319
+539
| +19% | +$55.9K | 0.02% | 170 |
|
|
2023
Q3 | $286K | Sell |
2,780
-246
| -8% | -$26.5K | 0.02% | 167 |
|
|
2023
Q2 | $349K | Sell |
3,026
-74
| -2% | -$8.4K | 0.03% | 169 |
|
|
2023
Q1 | $330K | Buy |
3,100
+385
| +14% | +$41.6K | 0.02% | 170 |
|
|
2022
Q4 | $301K | Sell |
2,715
-158
| -5% | -$16.1K | 0.02% | 174 |
|
|
2022
Q3 | $247K | Buy |
2,873
+403
| +16% | +$36K | 0.02% | 183 |
|
|
2022
Q2 | $225K | Sell |
2,470
-283
| -10% | -$25.1K | 0.02% | 197 |
|
|
2022
Q1 | $226K | Sell |
2,753
-48
| -2% | -$3.78K | 0.02% | 193 |
|
|
2021
Q4 | $215K | Sell |
2,801
-219
| -7% | -$17.4K | 0.02% | 209 |
|
|
2021
Q3 | $227K | Buy |
3,020
+407
| +16% | +$31K | 0.02% | 189 |
|
|
2021
Q2 | $203K | Sell |
2,613
-641
| -20% | -$47.7K | 0.02% | 199 |
|
|
2021
Q1 | $239K | Sell |
3,254
-3,683
| -53% | -$272K | 0.02% | 185 |
|
|
2020
Q4 | $541K | Hold |
6,937
| – | – | 0.07% | 138 |
|
|
2020
Q3 | $549K | Sell |
6,937
-760
| -10% | -$59.5K | 0.11% | 107 |
|
|
2020
Q2 | $568K | Hold |
7,697
| – | – | 0.12% | 104 |
|
|
2020
Q1 | $565K | Sell |
7,697
-554
| -7% | -$43.5K | 0.15% | 96 |
|
|
2019
Q4 | $716K | Sell |
8,251
-569
| -6% | -$46.7K | 0.15% | 95 |
|
|
2019
Q3 | $708K | Sell |
8,820
-105
| -1% | -$8.41K | 0.14% | 96 |
|
|
2019
Q2 | $714K | Sell |
8,925
-503
| -5% | -$38.5K | 0.14% | 99 |
|
|
2019
Q1 | $748K | Sell |
9,428
-812
| -8% | -$60.7K | 0.15% | 93 |
|
|
2018
Q4 | $747K | Hold |
10,240
| – | – | 0.11% | 122 |
|
|
2018
Q3 | $693K | Buy |
10,240
+1,383
| +16% | +$88.1K | 0.09% | 125 |
|
|
2018
Q2 | $513K | Buy |
8,857
+614
| +7% | +$34.6K | 0.07% | 136 |
|
|
2018
Q1 | $428K | Sell |
8,243
-125
| -1% | -$6.75K | 0.06% | 145 |
|
|
2017
Q4 | $449K | Sell |
8,368
-106
| -1% | -$5.88K | 0.06% | 146 |
|
|
2017
Q3 | $518K | Buy |
8,474
+94
| +1% | +$5.7K | 0.07% | 139 |
|
|
2017
Q2 | $512K | Sell |
8,380
-3,797
| -31% | -$231K | 0.07% | 131 |
|
|
2017
Q1 | $738K | Sell |
12,177
-4,839
| -28% | -$294K | 0.11% | 123 |
|
|
2016
Q4 | $956K | Buy |
17,016
+1,101
| +7% | +$64.4K | 0.14% | 114 |
|
|
2016
Q3 | $948K | Sell |
15,915
-547
| -3% | -$32K | 0.14% | 112 |
|
|
2016
Q2 | $905K | Hold |
16,462
| – | – | 0.13% | 112 |
|
|
2016
Q1 | $831K | Sell |
16,462
-314
| -2% | -$15.4K | 0.12% | 114 |
|
|
2015
Q4 | $846K | Buy |
16,776
+378
| +2% | +$19.1K | 0.12% | 119 |
|
|
2015
Q3 | $773K | Sell |
16,398
-741
| -4% | -$39.4K | 0.11% | 121 |
|
|
2015
Q2 | $931K | Buy |
17,139
+343
| +2% | +$19.2K | 0.12% | 121 |
|
|
2015
Q1 | $921K | Sell |
16,796
-2,886
| -15% | -$163K | 0.12% | 122 |
|
|
2014
Q4 | $1.07M | Sell |
19,682
-851
| -4% | -$47.4K | 0.13% | 114 |
|
|
2014
Q3 | $1.16M | Sell |
20,533
-1,227
| -6% | -$68.9K | 0.15% | 110 |
|
|
2014
Q2 | $1.2M | Sell |
21,760
-1,865
| -8% | -$102K | 0.15% | 107 |
|
|
2014
Q1 | $1.28M | Sell |
23,625
-367
| -2% | -$19K | 0.17% | 105 |
|
|
2013
Q4 | $1.15M | Sell |
23,992
-1,794
| -7% | -$82K | 0.15% | 109 |
|
|
2013
Q3 | $1.17M | Buy |
25,786
+13,281
| +106% | +$606K | 0.16% | 107 |
|
|
2013
Q2 | $554K | Buy |
+12,505
| New | +$559K | 0.08% | 128 |
|
Other funds holding MRK
Osborne Partners Capital Management's MRK Position: Q2 2026 in Review
Osborne Partners Capital Management increased its Merck (MRK) stake by 17% in Q2 2026, buying an estimated $46.8K and bringing the position to 2,811 shares worth $361K. The position accounts for 0.02% of the portfolio, ranked #170.
Osborne Partners Capital Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.28M in Q1 2014. 3,820 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Osborne Partners Capital Management held 2,811 shares of Merck worth $361K as of Q2 2026.
- Osborne Partners Capital Management bought 400 Merck shares in Q2 2026, an estimated $46.8K.
- Merck made up 0.02% of Osborne Partners Capital Management's portfolio in Q2 2026, its #170 holding.
- Osborne Partners Capital Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- Osborne Partners Capital Management's Merck position peaked at $1.28M in Q1 2014.
- 3,820 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Osborne Partners Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.